BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stirnadel-Farrant H, Kudari M, Garman N, Imrie J, Chopra B, Giannelli S, Gabaldo M, Corti A, Zancan S, Aiuti A, Cicalese MP, Batta R, Appleby J, Davinelli M, Ng P. Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID. Orphanet J Rare Dis. 2018;13:49. [PMID: 29625577 DOI: 10.1186/s13023-018-0791-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Enriquez-Ochoa D, Robles-Ovalle P, Mayolo-Deloisa K, Brunck MEG. Immobilization of Growth Factors for Cell Therapy Manufacturing. Front Bioeng Biotechnol 2020;8:620. [PMID: 32637403 DOI: 10.3389/fbioe.2020.00620] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
2 Michelsen S, Nachi S, Van Dyck W, Simoens S, Huys I. Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies. Front Pharmacol 2020;11:594446. [PMID: 33363468 DOI: 10.3389/fphar.2020.594446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Allan KM, Farrow N, Donnelley M, Jaffe A, Waters SA. Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies. Front Pharmacol 2021;12:639475. [PMID: 33796025 DOI: 10.3389/fphar.2021.639475] [Reference Citation Analysis]
4 Huang D, Zhao D, Li J, Wu Y, Du L, Xia XH, Li X, Deng Y, Li Z, Huang Y. Continuous Vector-free Gene Transfer with a Novel Microfluidic Chip and Nanoneedle Array. Curr Drug Deliv 2019;16:164-70. [PMID: 30332957 DOI: 10.2174/1567201815666181017095044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Del Pozo-Rodríguez A, Rodríguez-Gascón A, Rodríguez-Castejón J, Vicente-Pascual M, Gómez-Aguado I, Battaglia LS, Solinís MÁ. Gene Therapy. Adv Biochem Eng Biotechnol 2020;171:321-68. [PMID: 31492963 DOI: 10.1007/10_2019_109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Singh P, Singh A, Shah S, Vataliya J, Mittal A, Chitkara D. RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme. Mol Pharm 2020;17:4040-66. [PMID: 32902291 DOI: 10.1021/acs.molpharmaceut.0c00709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Van Pham P, Nguyen HT, Vu NB. Evolution of Stem Cell Products in Medicine: Future of Off-the-Shelf Products. In: Pham PV, editor. Stem Cell Drugs - A New Generation of Biopharmaceuticals. Cham: Springer International Publishing; 2018. pp. 93-118. [DOI: 10.1007/978-3-319-99328-7_6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Xie M, Viviani M, Fussenegger M. Engineering precision therapies: lessons and motivations from the clinic. Synth Biol (Oxf) 2021;6:ysaa024. [PMID: 33817342 DOI: 10.1093/synbio/ysaa024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Deola S, Guerrouahen BS, Sidahmed H, Al-Mohannadi A, Elnaggar M, Elsadig R, Abdelalim EM, Petrovski G, Gadina M, Thrasher A, Wels WS, Hunger SP, Wang E, Marincola FM, Maccalli C, Cugno C; ATH Consortium. Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar). J Transl Med 2018;16:276. [PMID: 30305089 DOI: 10.1186/s12967-018-1652-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Fonseca DA, Amaral I, Pinto AC, Cotrim MD. Orphan drugs: major development challenges at the clinical stage. Drug Discov Today 2019;24:867-72. [PMID: 30658132 DOI: 10.1016/j.drudis.2019.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Mansouri V, Beheshtizadeh N, Gharibshahian M, Sabouri L, Varzandeh M, Rezaei N. Recent advances in regenerative medicine strategies for cancer treatment. Biomed Pharmacother 2021;141:111875. [PMID: 34229250 DOI: 10.1016/j.biopha.2021.111875] [Reference Citation Analysis]
12 Tucci F, Scaramuzza S, Aiuti A, Mortellaro A. Update on Clinical Ex Vivo Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic Diseases. Mol Ther 2021;29:489-504. [PMID: 33221437 DOI: 10.1016/j.ymthe.2020.11.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
13 Ma C, Wang Z, Xu T, He Z, Wei Y. The approved gene therapy drugs worldwide: from 1998 to 2019. Biotechnology Advances 2020;40:107502. [DOI: 10.1016/j.biotechadv.2019.107502] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 73.0] [Reference Citation Analysis]